|Previous Section||Home Page|
Sao Tome e Principe
The territories formerly comprising the Socialist Republic of Yugoslavia, excluding Croatia and Slovenia
Mr. Llwyd: To ask the Parliamentary Secretary, Lord Chancellor's Department how much money was spent on central administration and policy formulation by his Department in 1993 94; what are the projections for (a) 1994 95 and (b) 1995 96; and if he will make a statement. 
Mr. John M. Taylor: Details of my Department's running costs and administrative spending for the years 1989 90 to 1997 98 are contained in table 4 of my Department's annual report, Cm 2809, copies of which are available in the Members' Library.
Mr. Wilson: To ask the Secretary of State for Health (1) what studies her Department has made of the side-effects of chorion villus sampling for Down's syndrome; and if she will take steps to ensure that all prospective parents are provided with information on the possibility of abnormalities resulting from the tests;  (2) how many CVS tests were provided under the NHS in each of the past five years and at what cost; and if she will list the manufacturers of these tests. 
Mr. Sackville: The results of a major Government-funded Medical Research Council clinical trial conducted in a number of international centres and examining the use of chorion villus sampling were published in 1991 and the findings published in The Lancet , copies of which are available in the Library. This also highlighted the possibility of a risk of limb reduction deformities associated with the procedure. Health professionals involved in conducting CVS would be aware of these findings and therefore in a position to advise parents of the potential risks involved, including that of miscarriage.
Information is not available centrally about the number or cost of the tests. The procedure involves tests undertaken usually in national health service laboratories, on placental tissue taken from the woman by CVS. There are therefore no manufacturers of these tests.
Medical Research Council European Trial of Chorion Villus Sampling, The Lancet , vol 337: 1491 1499, 22 June 1991.
Notification of babies born with Downs Syndrome in England and Wales, 1984-1993 Year |Numbers ------------------------ 1984 |505 1985 |442 1986 |445 1987 |459 1988 |428 1989 |487 1990 |415 1991 |440 1992 |394 1993 |311
Data were obtained from the national congenital malformation notification scheme. For the years given, the data were collected for live and stillbirths where the malformation was identified at or within 10 days of birth.
Mr. Alan Howarth: To ask the Secretary of State for Health if the Government will continue to identify an element for support of independent living within the revenue support grant for local authorities from 1996 97; and if she will make a statement. 
Mr. Bowis: Currently, an element of the special transitional grant for community care is identified as relating to the former independent living fund. It is not separately ring-fenced and local authorities are free to use it for any community care service. Whether former independent living fund resources will continue to be separately identified after the special transitional grant ends has not yet been determined.
Mr. Gordon Prentice: To ask the Secretary of State for Health if she will encourage and fund research into the therapeutic use of cannabis with double blind trials designed to established the efficacy or otherwise of this form of treatment. 
Mr. Bowis: The main agency through which the Government support medical and related biological research is the Medical Research Council, which receives its grant in aid from the office of my right hon. Friend the Chancellor of the Duchy of Lancaster. It is always willing to consider scientifically sound proposals. As for any other unlicensed product, a sponsor seeking a product licence for cannabis would need to present supporting data to the Medicines Control Agency, which would evaluate any application made to it in the normal way.
Mr. Jim Cunningham: To ask the Secretary of State for Health if she will make a statement on the adequacy of the provision of nursing homes for poor elderly people; and what information she has on the equivalent provision in each of the other European Union states. 
Mr. Bowis: Matters of quality and quantity of local nursing homes, irrespective of the income levels of residents, are for local commissioning authorities. We do not hold information on nursing homes in other European countries centrally.
Mr. Nicholas Brown: To ask the Secretary of State for Health what plans she has for granting prescription charge exemptions to people with splenectomies who require prophylactic doses of penicillin. 
Mr. Nicholas Brown: To ask the Secretary of State for Health how many applicants there were per GP trainee post (a) nationally, (b) regionally and (c) broken down by each FHSA in the current year and for each of the last 10 years. 
Mr. Sackville: The White Paper "The Health of the Nation" sets a target of 20 per cent. for adults smoking by the year 2000. In view of their higher smoking rates, it is clearly essential to reach people on low incomes if this is to be achieved.
This will be done through the comprehensive programme set out in the White Paper and the action plan "Smoke Free for Health" including health education, action on price, advice from general practitioners and other health professionals and proper controls on advertising and promotion.
Copies of both documents are available in the Library.
Mr. Nicholas Brown: To ask the Secretary of State for Health what plans she has to reduce the requirement on health boards for formal consultation when major changes to health services are planned. 
Mr. Nicholas Brown: To ask the Secretary of State for Health when she expects consultations with representatives of the Association of Optometrists on the GOS sight test fee for 1995 96 to begin. 
Mr. John Fraser: To ask the Secretary of State for Health what response she intends to make to the representations to her from the London borough of Lambeth in relation to the reform of the system for registering births, marriages and deaths. 
Mr. Sackville: The London borough of Lambeth has been advised that the Government intend to introduce legislation to implement the proposals in the White Paper entitled "Registration: proposals for change", Cm 939, when parliamentary time allows.
Mr. Forman: To ask the Secretary of State for Health if she will make a statement on the provision of accident and emergency services at hospitals serving the constituency of Carshalton and Wallington. 
Mr. Sackville: Merton, Sutton and Wandsworth health authority is responsible for purchasing accident and emergency services for Carshalton and Wallington residents. My hon. Friend may wish to contact Mr. Harry Cowd, chairman of the health authority, for details.
Mr. Malone: My right hon. Friend the Secretary of State for Health published today the Department of Health's response to the report of the review committee on the national health service complaints procedures, chaired by Professor Wilson, vice-chancellor of Leeds university, in a document "Acting on Complaints". Copies of this document will be placed in the Library.
Mr. Thurnham: To ask the Secretary of State for Health what level of immunisation coverage has been achieved by the measles rubella campaign; and what impact this has had on the number of cases of measles. 
Mrs. Virginia Bottomley: Very high immunisation coverage has been achieved by the campaign so far, and efforts are still being made to reach those children who have not yet been immunised. Coverage in England is 92